Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Diseases

Explore clinical trials studying Urinary Bladder Diseases. Study availability and eligibility vary by location and protocol.

2,289 public trials 414 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Diseases trial results

Completed

Phase I / II Study of Enadenotucirev by Sub-acute Fractionated IV Dosing in Cancer Patients

NCT02028442

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +20 more
Locations
  • GZA ziekenhuizen campus Sint-Augustinus Wilrijk, Antwerp, Belgium
  • Cliniques Universitaires St Luc Brussels, Belgium
  • Ghent University Hospital Ghent, Belgium
  • Institut Catala d Oncologica Barcelona, Spain
View Trial Details
Completed

Evaluation of the Efficacy and Safety of Solabegron Tablets for Treatment of Overactive Bladder in Adult Women

NCT03475706

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
Locations
  • Velicept Investigative Site - Birmingham Birmingham, Alabama, United States
  • Velicept Investigative Site - Gulf Shores Gulf Shores, Alabama, United States
  • Velicept Investigative Site - Mobile Mobile, Alabama, United States
  • Velicept Investigative Site - Tempe Tempe, Arizona, United States
View all 86 locations
View Trial Details
Completed

A Study to Evaluate Once Daily Low Dose and High Dose Solabegron or Placebo Given for 12 Weeks to Treat Women With Symptoms of Overactive Bladder: Sudden Urge to Urinate, Frequent Urination Associated With Wetting Episodes (VEL-2001)

NCT03594058

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
Locations
  • Velicept Investigative Site - Birmingham Birmingham, Alabama, United States
  • Velicept Investigative Site - Birmingham Birmingham, Alabama, United States
  • Velicept Investigative Site - Guntersville Guntersville, Alabama, United States
  • Velicept Investigative Site - Saraland Saraland, Alabama, United States
View all 77 locations
View Trial Details
Completed

A Study to Evaluate Tolerability and Participants Preference Between Mirabegron and Tolterodine Extended Release (ER) in Participants With Overactive Bladder (OAB)

NCT02138747

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
Locations
  • Site US10002 Urology Centers of Alabama Homewood, Alabama, United States
  • Site US10004 Alaska Clinical Research Center, LLC Anchorage, Alaska, United States
  • Site US10001 Urological Associates of Southern Arizona Tucson, Arizona, United States
  • Site US10003 Genesis Research San Diego, California, United States
View all 30 locations
View Trial Details

Related conditions